Bujarski J. Robert's most recent trade in QuidelOrtho Corporation was a trade of 390 Common Stock done . Disclosure was reported to the exchange on Oct. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 390 | 45,027 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 390 | 390 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.20 per share. | 15 Oct 2024 | 217 | 44,810 (0%) | 0% | 40.2 | 8,723 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2024 | 314 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2024 | 314 | 44,814 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.47 per share. | 14 Sep 2024 | 177 | 44,637 (0%) | 0% | 45.5 | 8,048 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | Interim President, EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 4,925 | 47,305 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | Interim President, EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2024 | 4,925 | 9,850 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | Interim President, EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.94 per share. | 28 Mar 2024 | 2,805 | 44,500 (0%) | 0% | 47.9 | 134,472 | Common Stock |
| QuidelOrtho Corporation | Bujarski J. Robert | Interim President, EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 21,367 | 21,367 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Bujarski J. Robert | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2024 | 1,052 | 42,820 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 1,052 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Bujarski Robert J. | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.15 per share. | 10 Feb 2024 | 575 | 42,245 (0%) | 0% | 68.1 | 39,186 | Common Stock |
| QuidelOrtho Corporation | Bujarski J. Robert | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 315 | 0 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | J. Robert Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2024 | 315 | 42,560 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert Bujarski J. | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.15 per share. | 10 Feb 2024 | 180 | 42,380 (0%) | 0% | 68.2 | 12,267 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 17,905 | 17,905 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Bujarski Robert J. | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 1,660 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | J. Bujarski Robert | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 1,660 | 42,714 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Bujarski J. Robert | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.34 per share. | 01 Feb 2024 | 946 | 41,768 (0%) | 0% | 68.3 | 64,650 | Common Stock |
| QuidelOrtho Corporation | Bujarski J. Robert | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 879 | 41,555 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Bujarski J. Robert | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 879 | 879 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | J. Robert Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.45 per share. | 01 Feb 2024 | 501 | 41,054 (0%) | 0% | 69.4 | 34,794 | Common Stock |
| QuidelOrtho Corporation | J. Bujarski Robert | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 6,772 | 44,533 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 6,772 | 6,773 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | J. Bujarski Robert | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.51 per share. | 31 Jan 2024 | 3,857 | 40,676 (0%) | 0% | 68.5 | 264,243 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 3,219 | 39,685 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Bujarski J. Robert | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 3,219 | 6,440 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | J. Robert Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.51 per share. | 31 Jan 2024 | 1,924 | 37,761 (0%) | 0% | 68.5 | 131,813 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2023 | 390 | 780 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2023 | 390 | 36,660 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.02 per share. | 15 Oct 2023 | 194 | 36,466 (0%) | 0% | 68.0 | 13,196 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2023 | 314 | 314 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 314 | 36,426 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.37 per share. | 14 Sep 2023 | 156 | 36,270 (0%) | 0% | 76.4 | 11,914 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 14,775 | 14,775 | - | - | Non-Qualified Stock Option | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 14,775 | 14,775 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2023 | 2,749 | 37,103 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,749 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.50 per share. | 11 Feb 2023 | 1,381 | 35,722 (0%) | 0% | 86.5 | 119,457 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 824 | 0 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2023 | 824 | 36,546 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.50 per share. | 11 Feb 2023 | 434 | 36,112 (0%) | 0% | 86.5 | 37,541 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 3,623 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 3,623 | 36,259 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.70 per share. | 03 Feb 2023 | 1,905 | 34,354 (0%) | 0% | 89.7 | 170,879 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 1,660 | 33,509 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,660 | 1,660 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.70 per share. | 03 Feb 2023 | 873 | 32,636 (0%) | 0% | 89.7 | 78,308 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 3,219 | 33,204 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 3,219 | 9,659 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.61 per share. | 31 Jan 2023 | 1,771 | 31,433 (0%) | 0% | 85.6 | 151,615 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 879 | 1,758 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 879 | 32,312 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | EVP & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.51 per share. | 31 Jan 2023 | 463 | 31,849 (0%) | 0% | 88.5 | 40,980 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 1,033 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 1,033 | 30,529 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.40 per share. | 18 Nov 2022 | 544 | 29,985 (0%) | 0% | 88.4 | 48,090 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2022 | 389 | 29,701 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 389 | 1,170 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.29 per share. | 15 Oct 2022 | 205 | 29,496 (0%) | 0% | 76.3 | 15,639 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2022 | 313 | 628 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 313 | 29,477 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.25 per share. | 14 Sep 2022 | 165 | 29,312 (0%) | 0% | 83.2 | 13,736 | Common Stock |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 29,164 | 0 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 29,164 | 29,164 (0%) | 0% | - | Common Stock | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 17,596 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 17,596 | 17,596 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 14,343 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 14,343 | 14,343 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 13,545 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 13,545 | 13,545 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 12,878 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 12,878 | 12,878 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 12,876 | 12,876 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 12,876 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 9,212 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 9,212 | 9,212 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 8,798 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 8,798 | 8,798 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 7,246 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 7,246 | 7,246 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 6,641 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 6,641 | 6,641 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 3,623 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 3,623 | 3,623 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 3,514 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 3,514 | 3,514 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 3,320 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 3,320 | 3,320 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 2,935 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,935 | 2,935 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 2,749 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,749 | 2,749 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 2,637 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,637 | 2,637 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 1,559 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 1,559 | 1,559 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 1,351 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 1,351 | 1,351 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Robert J. Bujarski | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 1,190 | 0 | - | - | Restricted Stock Units |